Tag Archives: Mist

Primatene Mist Coming Back; Some Docs Concerned

Jason Shandell, president, Amphastar Pharmaceuticals Inc., Rancho Cucamonga, CA. Sandy Walsh, spokeswoman, FDA. FDA: “CDER Conversation: Safely Using the Newly Available OTC Asthma Inhaler Primatene Mist.” James Li, MD, PhD, professor of medicine, Mayo Clinic, Rochester, MN; former president, American Academy of Allergy, Asthma & Immunology. Dacia Morris, spokeswoman, American Thoracic Society, New York City.… Read More »

FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma

Print this page RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (FDA) granted approval of its New Drug Application (NDA) for Primatene Mist (epinephrine inhalation aerosol bronchodilator suspension), which is delivered by a metered dose inhaler (MDI) with a non-chlorofluorocarbon… Read More »